NEW YORK, March 17, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Natus Medical Incorporated (“Natus”) (NASDAQ:BABY) between October 16, 2015 and April 3, 2016. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Northern District of California. To get more information go to:
http://www.zlk.com/pslra/natus-medical-incorporated
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts, including that: (1) the Venezuelan government failed to make tens of millions of dollars in prepayments to Natus, which were required to have been paid beginning in October 2015; (2) Natus had no means to effectively enforce its rights under its supply contract, as Venezuela was the exclusive forum for dispute resolution; (3) Natus’ receipt of revenues pursuant to the supply contract was contingent on the outcome of Venezuelan elections; and (4) as a result, Natus was not on track to achieve the increased guidance provided by Defendants, which lacked a reasonable basis.
If you suffered a loss in Natus you have until March 31, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
Hyundai Plans 20 New Models in China to Boost EV Strategy and Market Share
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
John Ternus Signals Apple’s Future with Product-First AI Strategy
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 



